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ABSTRACT
Objective: The study aimed to development and validation of simple, precise, and reliable high-performance thin-layer chromatography (HPTLC) for 
the determination of terbutaline sulfate (TBS), bromhexine hydrochloride (BRH), and etophylline (ETP) in pharmaceutical dosage form.
Methods: A simple, precise, rapid, and accurate HPTLC method was developed for the estimation of TBS, BRH, and ETP in pharmaceutical dosage form. 
Pre-coated silica gel G60 F254 aluminum sheet (10 cm2×10 cm2 and thickness 0.2 mm) was used as stationary phase while mobile phase consisting of 
benzene: methanol:glacial acetic acid 8:0.5:1.5 v/v/v detection at 275 nm. The present method had validated according to ICH guidelines.
Results: Migration distance found 80 mm at 275 nm. The retention factor found to be 0.24, 0.57, and 0.68, respectively. The detector response was 
linear in the concentration range of 60–210 ng/band, 2400–8400 ng/band, and 96–336 ng/band, respectively. The linear regression equation being 
Y=32.20x−562.9, Y=11.79x−1711, and Y=1.756x−5636, respectively. The limit of detection for TBS 0.677 µg, for BRH 8.123 µg, and for ETP 57.915 µg 
and limit of quantification to be 2.053, 24.617, and 175.5 µg, respectively, were found. The developed method validated by ICH guideline, i.e., accuracy, 
precision, robustness, specificity, and system suitability.
Conclusion: In this study, we had developed a simple, fast, and reliable HPTLC method for the determination of TBS, BRH, and ETP in pharmaceutical 
dosage form.
Keywords: Terbutaline sulfate, Bromhexine hydrochloride, Etophylline, High-performance thin-layer chromatography, ICH guidelines, Simultaneous 
estimation, Tablet.
INTRODUCTION
Terbutaline sulfate (TBS) is a selective beta-2 adrenergic agonist used 
as a bronchodilator and mucolytic; etophylline (ETP) is non-selective 
phosphor diesterase inhibitor and acts as cardiac stimulant and 
bronchodilator while bromhexine hydrochloride (BRH) is a mucolytic 
agent. Combination is used in the treatment of respiratory disorders 
associated with viscid or excessive mucus. Estimation of TBS and BRH 
is reported in Indian pharmacopoeia while ETP reported in European 
pharmacopoeia. Literature review revealed that the estimation of 
ternary mixture containing salbutamol sulfate, BRH, and ETP by thin-
layer chromatography (TLC) method [1]. Determination of BRH in 
pharmaceuticals by TLC densitometry method [2], determination of 
TBS in human plasma by high-performance TLC (HPTLC) [3], stability-
indicating HPTLC method for the determination of terbutaline 
sulfate in bulk and from submicronized dry powder inhalers [4], and 
development and validation of HPTLC method for the determination 
of BRH in human plasma [5,6] have been reported. In this work, an 
attempt made to develop economical and rapid HPTLC method for 




Quantitative method has been developed using CAMAG HPTLC 
instrument. For estimation, Camag Linomat V (semiautomatic 
application, band application by spray-on technique) (2–500 µL), 
Hamilton syringe (100 µL), Camag TLC Scanner IV (scanning speed up to 
100 mm/s, spectral range 190–800 nm), Camag Twin Trough Chamber 
(10 cm2× 10 cm and 20 cm× 10 cm), dual-wavelength ultraviolet cabinet 
(dual-wavelength 254 and 366 nm), and Camag winCATS software 
V1.4.7 have used.
Chemicals and solvents
TBS, BRH, and ETP procured from Nirlife Healthcare, Nirma Ltd., 
Ahmedabad, India, as gratis samples. The solvents used methanol, 
benzene, and glacial acetic acid of analytical reagent (AR) grade 
purchased from Loba Chemicals, Mumbai, India. Commercial tablets of 
TBS 2.5 mg, BRH 4 mg, and ETP 100 mg purchased from local market.
Selection of mobile phase
On the basis of various trial taken for optimized mobile phase for 
simultaneous estimation of TBS, BRH, and ETP, the mobile phase 
comprised phase benzene, methanol, and glacial (8:0.5:1.5 v/v/v) 
produces better separation of peak with resolution and 
reproducibility as shown in Fig. 1.
Preparation of the mobile phase and diluents
The mobile phase prepared by mixture of benzene: methanol:glacial 
acetic acid in the ratio of 8:0.5:1.5 v/v/v, respectively.
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Preparation of system suitability solution (standard solution)
TBS stock solution (1 mg/mL)
100 mg of TBS transferred to 100 mL volumetric flask, dissolved, 
and diluted up to the mark with methanol to get TBS stock solution 
containing 1 mg/mL of TBS.
ETP stock solution (1 mg/mL)
Weigh 100 mg of ETP and transferred to 100 mL volumetric flask, 
dissolved, and diluted up to the mark with methanol to get ETP stock 
solution containing 1 mg/mL of ETP.
BRH stock solution (1 mg/mL)
Accurately weighed 100 mg of BRH transferred to 100 mL volumetric 
flask, dissolved, and diluted up to the mark with methanol to get BRH 
stock solution containing 1 mg/mL of BRH.
Preparation of working standard solution for calibration curve
The aliquot (0.075 mL) of TBS, (3 mL) ETP, and (0.12 mL) BRH stock 
solutions were transferred into 10 mL volumetric flask and diluted up 
to the mark with methanol to prepare mixture of working standard 
solution containing 7.5 µg/mL of TBS, 300 µg/mL of ETP, and 12 µg/mL 
of BRH.
Preparation of sample solutions
Twenty tablets precisely weighed and crushed. Weight equivalent to 
2.5 mg of TBS, 100 mg of ETP, and 4 mg of BRH. The powder transferred 
to 100 mL volumetric flask. Powder dissolved in 20 mL of methanol and 
sonicate the solution for 45 min, filter it through Whatman filter paper 
No. 41 and diluted up to 100 mL with methanol to prepare solution 
containing 25 µg/mL of TBS, 1000 µg/mL of ETP, and 40 µg/mL BRH. 
Withdraw 3 mL solution from it, transferred to 10 mL to volumetric 
flask and dilute up to the mark with methanol to prepare solution 
containing 7.5 µg/mL of TBS, 300 µg/mL of ETP, and 12 µg/mL BRH 
(test solution).
Chromatographic condition
Working standard solution (12 µL) or sample solution for analysis of 
formulation (12 µL) was spotted on the pre-washed TLC plate and 
developed with mobile phase benzene: methanol:glacial acetic acid in 
the ratio of 8:0.5:1.5 v/v/v, respectively. Photometric measurements 
performed at 275 nm in absorbance/reflectance mode with Camag TLC 
Scanner-V using winCATS V 1.4.7 software.
METHODS
Working standard solution (12 µL) or sample solution for analysis 
of formulation (12 µL) spotted on the pre-washed TLC plate under 
nitrogen stream with semi-automatic spotter. Plate dried under IR 
lamp and developed in a Twin Trough Chamber previously saturated 
mobile phase benzene: methanol:glacial acetic acid in the ratio of 
8:0.5:1.5 v/v/v, respectively. After development, the plate dried in 
oven. Photometric measurements performed at 275 nm in absorbance/
reflectance mode with Camag TLC Scanner-V using winCATS V 1.4.7 
software incorporating the track optimization option. Six replicates of 
each standard solution of TBS, ETP, and BRH were determined in the 
range of 60–210 ng/band, 2400–8400 ng/band, and 96–336 ng/band, 
respectively. Calibration graph plotted by the concentration of TBS, ETP, 
and BRH on X-axis and peak area on Y-axis and linearity curve is shown 
in Fig. 2. The amount of drug present in the sample had computed by 
calibration graph.
RESULTS AND DISCUSSION
The objective of the present work is to develop simple, precise, and 
reliable HPTLC method for the analysis of TBS, BRH, and ETP in bulk 
and pharmaceutical dosage forms. This was achieved using the most 
commonly employed Silica gel G60 F254 aluminum sheet (10 cm×10 cm 
and 10 cm×20 cm) column detection at 275 nm. The representative 
densitogram indicates TBS, BRH, and ETP.
Parameter fixation
In developing this method, a systemic study of the effects of various 
parameters was conducted by varying one parameter at a time and 
controlling all others. The following studies conducted for this purpose. 
Optimized chromatographic conditions of terbutaline sulfate, bromhexine 
hydrochloride, and etophylline parameters shown in (Table  1).
Mobile phase characteristics
Various experiments were conducted by changing composition of mobile 
phase and flow rate to achieve significant separation and resolution. 
For ideal separation of the drugs, AR grade benzene, methanol, and 
glacial acetic acid were used in the ratio of 8:0.5:1.5 (v/v/v) which 
were proved to be the best suitable of all the combinations since the 
chromatographic peak obtained was better resolved and free from 
tailing and fronting.
Linearity
A linearity study verifies that the sample solutions are in a 
concentration range where analytes response is linearly proportional 
to concentration. The linearity of response for the present method was 
determined by analyzing standard solution of TBS, ETP, and BRH which 
were determined in the range of 60–210 ng/band, 2400–8400 ng/band, 
and 96–336 ng/band, respectively (Fig. 3). The results have shown that 
the peak areas are linear within the concentration of analysis. The 
correlation coefficient was r2=0.998, 0.999, and 0.997, respectively 
(Figs. 4-6). Result of linearity study shown in Table 2.
Accuracy
The accuracy calculated by standard addition method. A known 
amount of standard drug had added to the fixed amount of pre-
analyzed standard solution. The percent recovery and percentage 
Fig. 1: Thin-layer chromatography plate of terbutaline sulfate, 
etophylline, and bromhexine hydrochloride
Fig. 2: Typical chromatogram of terbutaline sulfate Rf=0.24±0.02, 
ETP Rf=0.57±0.02, and BRH Rf=0.68±0.02
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relative standard deviation (% RSD) was calculated, and the results 
are presented in Tables 3-5. Satisfactory recoveries for all three drugs 
have obtained by the proposed method, which indicate that proposed 
method is accurate.
Intraday precision
To study the intraday precision, three standard solutions (90, 120, and 
150) of TBS, ETP, and BRH had spotted. The % RSD was calculated and 
it was found to be 0.31–0.40, 0.17–0.39, and 0.35–0.41 for TBS, ETP, and 
BRH, respectively, which are well within the acceptable criteria of not 
more than 2.0. Results are shown in Table 6.
Interday precision
To study the interday precision, standard solutions (90, 120, and 150) 
of TBS, ETP, and BRH have spotted. The % RSD was calculated and it 
was found to be 0.92–1.06, 0.86–1.37, and 1.24–1.42 for TBS, ETP, and 
BRH, respectively, which are well within the acceptable criteria of not 
more than 2.0. Results are shown in Table 7.
Specificity
The effect of a wide range of excipients and other additives normally 
presents in the combined dosage form of TBS, ETP, and BRH in 
the determinations under optimum conditions have performed. 
Chromatographic parameters maintained are specific for TBS, ETP, and 
BRH.
Limit of detection (LOD) and limit of quantification (LOQ)
The detection limit of the method has calculated by standard solutions 
of TBS, ETP, and BRH on TLC plate. Using the S/N method, the peak-
to-peak noise around the analytes retention time is calculated, and 
subsequently, the concentration of the analytes that would yield a signal 
equal to certain value of noise-to-signal ratio is measured. An S/N ratio 
of 3 is generally accepted for estimating LOD and S/N ratio of 10 is 
used for estimating LOQ. This method commonly applied to analytical 
methods that exhibit baseline noise. The LOD for TBS, ETP, and BRH 
was found to be 0.667, 57.915, and 8.123 ng/band, respectively. 
The LOQ for TBS, ETP, and BRH was found to be 2.053, 175.500, and 
24.617 ng/band, respectively.
Robustness
The HPTLC method has checked for robustness using Plackett–Burman 
(PB) design with 12 experiments [7-9]. Seven HPTLC conditions were 
screened: (a) Amount of benzene change in mobile phase composition, 
(b) change in amount of methanol in mobile phase, (c) change in 
amount of mobile phase volume, (d) saturation time change, (e) change 
in detection wavelength, (f) bandwidth change, and (g) change in 
Fig. 3: Overlay linearity chromatogram of terbutaline sulfate, 
etophylline, and bromhexine hydrochloride 60–210 ng/band, 
2400–8400 ng/band, and 96–336 ng/band, respectively
Fig. 4: Calibration curve for terbutaline sulfate
Fig. 5: Calibration curve for etophylline
Fig. 6: Calibration curve for bromhexine hydrochloride
Table 1: Optimized chromatographic conditions of terbutaline 
sulfate, bromhexine hydrochloride, and etophylline parameters
Parameters Value
Mobile phase Benzene: methanol: glacial acetic acid 
8:0.5:1.5 v/v/v
Stationary phase Pre-coated silica gel G60 F254 aluminum 






Run distance 8 cm
Detection wavelength 275 nm
Retention factor 0.24, 0.57, and 0.68, respectively
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Table 2: Linearity data of TBS, ETP, and BRH (n=6)
TBS ETP BRH
Concentration (ng/band) Mean area Concentration (ng/band) Mean area Concentration (ng/band) Mean area
60 1258.18 2400 9748.56 96 2871.68
90 2429.26 3600 12,115.45 144 3449.66
120 3361.26 4800 13,945.43 192 3899.13
150 4284.71 6000 16,284.33 240 4474.71
180 5194.9 7200 18,363.55 288 5168.75
210 6176.75 8400 20,287.65 336 5687.30
TBS: Terbutaline sulfate, ETP: Etophylline, BRH: Bromhexine hydrochloride




Mean area±SD* % RSD Concentration 
(ng/band)
Mean area±SD* % RSD Concentration 
(ng/band)
Mean area±SD* % RSD
90 2467.32±3.32 0.401 3600 12,187.23±16.94 0.293 144 3471.23±15.37 0.352
120 3392.65±3.24 0.362 4800 13,921.42±17.32 0.173 192 3831.63±13.64 0.412
150 4238.53±4.62 0.314 6000 16,195.53±47.32 0.391 240 4421.85±17.74 0.385
TBS: Terbutaline sulfate, ETP: Etophylline, BRH: Bromhexine hydrochloride, RSD: Relative standard deviation, SD: Standard deviation
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solvent run distance (Table 8). The selection of factors was based on 
observations during method development and own experience. Each 
factor has studied at two levels. The limits of the factors studied have 
selected according to error ranges, which would commonly found in an 
analytical laboratory.
The Design-Expert 9 software has used to set up the experimental 
designs for HPTLC method. The area for TBS, ETP, and BRH has 
observed at each experiment designed for HPTLC method. Combined 
standard solution of TBS (90 ng/band), ETP (3600 ng/band), and BRH 
(144 ng/band) was analyzed at each design experiment. The experiment 
has repeated 3 times. The experiments were executed in random order.
The obtained graphs are presented in Figs. 7-9. It may be more 
suitable for viewing the Pareto chart, which has the significant 
Fig. 7: Pareto chart for terbutaline sulfate
Fig.8: Pareto chart for etophylline
Fig. 9: Pareto chart for bromhexine hydrochloride
Table 8: Twelve experiments Plackett–Burman design 
to examine the seven high-performance thin-layer 
chromatography factors
Experiment Factors
A B C D E F G
1 −1 1 1 −1 1 1 1
2 1 −1 −1 −1 1 −1 1
3 1 −1 1 1 −1 1 1
4 1 1 −1 1 1 1 −1
5 1 1 −1 −1 −1 1 −1
6 −1 −1 1 −1 1 1 −1
7 −1 1 −1 1 1 −1 1
8 −1 1 1 1 −1 −1 −1
9 1 −1 1 1 1 −1 −1
10 1 1 1 −1 −1 −1 1
11 −1 −1 −1 −1 −1 −1 −1
12 −1 −1 −1 1 −1 1 1
Table 9: P value for robustness study
Factor p-value
TBS ETP BRH
A 0.2997 0.2848 0.5915
B 0.2180 0.6445 0.3684
C 0.4668 0.2006 0.2264
D 0.2721 0.2076 0.4362
E 0.7468 0.2983 0.2905
F 0.7386 0.5709 0.5708
G 0.9604 0.2752 0.7165
TBS: Terbutaline sulfate, ETP: Etophylline, BRH: Bromhexine hydrochloride






TBS ETP BRH TBS ETP BRH TBS ETP BRH
90 3600 144 89.22 3622.31 142.90 99.13 100.61 99.23
90 3600 144 89.34 3617.82 142.85 99.26 100.49 99.20
90 3600 144 89.77 3667.42 143.11 99.74 101.87 99.38
Mean 89.44 3635.85 142.96 99.37 100.99 99.27
SD 0.289 27.432 0.137 0.321 0.764 0.096
% RSD 0.323 0.754 0.102 0.323 0.766 0.101
TBS: Terbutaline sulfate, ETP: Etophylline, BRH: Bromhexine hydrochloride, 
RSD: Relative standard deviation, SD: Standard deviation




Mean area±SD* % RSD Concentration 
(ng/band)
Mean area±SD* % RSD Concentration 
(ng/band)
Mean area±SD* % RSD
90 2445.13±26.16 1.061 3600 12,183.63±122.43 1.026 144 3442.41±48.41 1.241
120 3372.53±23.52 0.972 4800 13,921.36±95.32 0.862 192 3801.31±72.43 1.426
150 4214.86±27.32 0.921 6000 16,181.42±130.54 1.374 240 4417.31±68.32 1.352
TBS: Terbutaline sulfate, ETP: Etophylline, BRH: Bromhexine hydrochloride, RSD: Relative standard deviation, SD: Standard deviation
301
Asian J Pharm Clin Res, Vol 12, Issue 9, 2019, 296-301
 Patel et al. 
effects selected. The Pareto graph (Figs. 6-8) consists of bars with 
a length proportional to the absolute value of the estimated effect, 
divided by the pseudo standard error (PSE) known by Lenth (Lenth’s 
PSE). All main effects and interaction terms found to be statistically 
insignificant as absolute values of main effects are below the critical 
t-value.
p<0.05 that means that factor is significantly effect on the response. 
However, here, no one is more than 0.05 means that method is robust 
as shown in Table 9.
CONCLUSION
In this study, a simple, accurate, rapid, reliable, and robust HPTLC 
method was developed and validated as per ICH guideline for the 
simultaneous determination of TBS, ETP, and BRH in combined 
pharmaceutical formulations. The result of formulation was found 
accurate and percentage assay obtained nearly 100% W/W for 
marketed formulation (as shown Table 10). Since the proposed methods 
has the lowest LOQ values for TBS, ETP, and BRH 2.053, 175.500, and 
24.617 ng/band, respectively. The HPTLC method found robust as 
robustness has checked using PB design with 12 experiments. From 
the results obtained, we concluded that the suggested methods showed 
high sensitivity, specificity, accuracy, and reproducibility. Moreover, 
the method was simple and inexpensive, and this could be useful for 
the routine quality control of TBS, ETP, and BRH in pharmaceutical 
formulations.
ACKNOWLEDGMENTS
The authors wish to thank the Nirlife Healthcare, Nirma Ltd., 
Ahmedabad, India, for supporting this work. This work was conducted 
at Ramanbhai Patel College of Pharmacy, Changa, Gujarat, India.
AUTHORS’ CONTRIBUTIONS
Mehul Patel and Jigisha Chauhan have conceived of the presented idea. 
Both have developed the theory and performed the experiments. Mehul 
Patel has verified and validated the analytical methods. Mehul Patel 
encouraged Jigisha Chauhan to the development of analytical methods 
and interpreted the findings of this work. All authors discussed the 
results and contributed to the final manuscript.
CONFLICTS OF INTEREST
The authors declare that there are no conflicts of interest regarding the 
publication of this paper.
REFERENCES
1. Dave HN, Mashr RC, Patel AK. Thin layer chromatography method 
for the determination of ternary mixture containing salbutamol 
sulphate, bromhexine hydrochloride and etofylline. Int J Pharm Sci Res 
2010;2:143-8.
2. Sumarlik E, Indrayanto G. TLC densitometric determination of 
bromhexine hydrochloride in pharmaceuticals, and its validation. J Liq 
Chromatogr Relat Technol 2004; 27:2047-56.
3. Dhoka MV, Gawande VT, Joshi PP. HPTLC determination of 
amoxicillin trihydrate and bromhexine hydrochloride in oral solid 
dosage forms. J Pharm Sci Res 2010;2:477-83.
4. Faiyazuddin M, Rauf A, Ahmad N, Ahmad S, Iqbal Z, Talegaonkar S, 
et al. A validated HPTLC method for determination of terbutaline sulfate 
in biological samples: Application to pharmacokinetic study. Saudi 
Pharm J 2011;19:185-91.
5. Faiyazuddin M, Ahmad S, Iqbal Z, Talegaonkar S, Ahmad FJ, 
Bhatnagar A, et al. Stability indicating HPTLC method for 
determination of terbutaline sulfate in bulk and from submicronized 
dry powder inhalers. Anal Sci 2010;26:467-72.
6. Rao MR, Kumar M, Aghav S, Sukre G. Development and validation 
of HPTLC method for determination of bromhexine hydrochloride in 
human plasma. Res J Pharm Technol 2012;5:1054-7.
7. Awotwe-Otoo D, Agarabi C, Faustino PJ, Habib MJ, Lee S, Khan MA, 
et al. Application of quality by design elements for the development 
and optimization of an analytical method for protamine sulfate. J Pharm 
Biomed Anal 2012;62:61-7.
8. Sheladia S, Patel B. Implementation of QBD approach to develop and 
validate analytical method for simultaneous estimation of duloxetine 
hydrochloride and methylcobalamine in pharmaceutical dosage form 
by HPTLC method. Int J Pharm Pharm Sci 2016;8:105-13.
9. Bhatt DA, Rane SI. QBD approach to analytical RPHPLC method 
development and its validation. Int J Pharm Pharm Sci 2011;3:179-87.
